about
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesEfficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia.Drug and vaccine access in the Ebola epidemic: advising caution in compassionate use.No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations.Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome.Practical allocation system for the distribution of specialised care during cellular therapy access scarcity
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Andrew Hantel
@en
Andrew Hantel
@nl
type
label
Andrew Hantel
@en
Andrew Hantel
@nl
prefLabel
Andrew Hantel
@en
Andrew Hantel
@nl
P31
P496
0000-0001-9612-3643